Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 06, 2022 08:30 ET | Source: ABVC BioPharma, Inc.

Zacks Places Share Value of ABVC BioPharma at $9.50

FREMONT, CA, July 06, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in...
June 30, 2022 08:30 ET | Source: ABVC BioPharma, Inc.

ABVC BioPharma Provides Vitargus® Update

Vitargus® Receives Phase II Thailand Central Research Ethics Committee Approval FREMONT, CA, June 30, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC), a...
June 21, 2022 08:30 ET | Source: ABVC BioPharma, Inc.

ABVC BioPharma Expands Co-Development Partnership With Rgene Corporation

FREMONT, CA, June 21, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in...
June 16, 2022 08:30 ET | Source: ABVC BioPharma, Inc.

ABVC BioPharma Submitted Vitargus® Phase II Study Plan to Australia HREC

FREMONT, CA, June 16, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in...
June 10, 2022 08:30 ET | Source: ABVC BioPharma, Inc.

ABVC BioPharma Announces Termination of Two Contracts

FREMONT, CA, June 10, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in...
June 01, 2022 08:30 ET | Source: ABVC BioPharma, Inc.

ABVC BioPharma Announces Enrollment Progress for ADHD Phase II Part 2 Clinical Study

FREMONT, CA, June 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in...
May 25, 2022 08:30 ET | Source: ABVC BioPharma, Inc.

ABVC BioPharma Engaged by Orion BioTech to Identify Global Licensing Partners

FREMONT, CA, May 25, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in...
May 23, 2022 07:30 ET | Source: ABVC BioPharma, Inc.

Prestigious Researchers to Provide Consulting Services in Connection with ABVC BioPharma's Depression Medicines

Fremont, CA, May 23, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in...
May 16, 2022 17:46 ET | Source: ABVC BioPharma, Inc.

ABVC Biopharma Reports First Quarter 2022 Financial and Operational Results

FREMONT, CA, May 16, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire--ABVC BioPharma, Inc. (Nasdaq: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in...
May 13, 2022 08:30 ET | Source: ABVC BioPharma, Inc.

ABVC BioPharma Engages the FreeMind Group to Support Grant Funding

FREMONT, CA, May 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in...